ConductScience.org, home

Paper7901434

Antiretroviral therapy for adult HIV-infected patients. Recommendations from a state-of-the-art conference. National Institute of Allergy and Infectious Diseases State-of-the-Art Panel on Anti-Retroviral Therapy for Adult HIV-Infected Patients.

Sande MA and 4 others. JAMA, 1993. Cited by 139 papers, by iCite.

Cite this record

ConductScience Library. Antiretroviral therapy for adult HIV-infected patients. Recommendations from a state-of-the-art conference. National Institute of Allergy and Infectious Diseases State-of-the-Art Panel on Anti-Retroviral Therapy for Adult HIV-Infected Patients. Papers, record 7901434. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7901434

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Antiretroviral therapy for adult HIV-infected patients. Recommendations from a state-of-the-art conference. National Institute of Allergy and Infectious Diseases State-of-the-Art Panel on Anti-Retroviral Therapy for Adult HIV-Infected Patients.
PubMed
Journal
JAMA
PubMed
Year
1993
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
139
iCite
Relative citation ratio, by iCite
4.57
iCite
Revised in PubMed
2019-07-01
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Sande MAM A
2Carpenter CCC C
3Cobbs CGC G
4Holmes KKK K
5Sanford JPJ P

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
DideoxynucleosidesMajor topic
HIV InfectionsMajor topic
Adult
CD4-Positive T-Lymphocytes
Clinical Trials as Topic
Didanosine
Drug Resistance
Guidelines as Topic
Humans
Leukocyte Count
Zalcitabine
Zidovudine

Source PubMed

Download CSV of topics

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment in7515116NIAID recommendations for treating HIV infection.https://conductscience.org/library/papers/7515116

Source PubMed

Download CSV of comments and corrections

Cited by15

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 139 citations.

PMIDTitleJournalYearIn PapersSource
26442227Postmarket safety of drugs approved by Health Canada on the basis of clinical and surrogate outcomes: a cohort study.CMAJ Open2015https://conductscience.org/library/papers/26442227PubMed
18476047Human immunodeficiency virus type 1 counseling and testing program in the prenatal setting.Infect Dis Obstet Gynecol1995https://conductscience.org/library/papers/18476047PubMed
11658016Statistics and ethics in medical research.Sci Eng Ethics1999https://conductscience.org/library/papers/11658016PubMed
9517872Frequency and determinants of use of antiretroviral and prophylactic therapies against Pneumocystis carinii Pneumonia (PCP) before AIDS diagnosis in Italy.Eur J Epidemiol1998https://conductscience.org/library/papers/9517872PubMed
9276664Effect of subspecialty training and experience on agreement with HIV guidelines.J Gen Intern Med1997https://conductscience.org/library/papers/9276664PubMed
9127225Zidovudine adherence in persons with AIDS. The relation of patient beliefs about medication to self-termination of therapy.J Gen Intern Med1997https://conductscience.org/library/papers/9127225PubMed
8884187Quality of life assessment and HIV infection: a review.Eur J Epidemiol1996https://conductscience.org/library/papers/8884187PubMed
8879972Treatment of HIV infection. Tolerability of commonly used antiretroviral agents.Drug Saf1996https://conductscience.org/library/papers/8879972PubMed
8595267Managing HIV disease after Delta.BMJ1996https://conductscience.org/library/papers/8595267PubMed
8593022Strategies for control of zidovudine concentrations in serum.Antimicrob Agents Chemother1995https://conductscience.org/library/papers/8593022PubMed
8583491Natural history of HIV-1 infection and predictors of survival in a cohort of HIV-1 seropositive injecting drug users.J Natl Med Assoc1996https://conductscience.org/library/papers/8583491PubMed
8562291Zidovudine therapy in HIV infection: which patients should be treated and when.Br J Clin Pharmacol1995https://conductscience.org/library/papers/8562291PubMed
7744265AZT toxicity and AIDS prophylaxis: is AZT beneficial for HIV+ asymptomatic persons with 500 or more T4 cells per cubic millimeter?Genetica1995https://conductscience.org/library/papers/7744265PubMed
7614902Early versus delayed treatment of HIV infection. Zidovudine should be given before symptoms develop.Drugs1995https://conductscience.org/library/papers/7614902PubMed
7574530Pharmacokinetics of clarithromycin and zidovudine in patients with AIDS.Antimicrob Agents Chemother1995https://conductscience.org/library/papers/7574530PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/7901434

GET https://conductscience.org/api/papers/v1/7901434/authors